// App-Quantinova.ai

513 : Standardization of technologies for CTC, ctDNA and miRNA enrichment, isolation and analysis for liquid biopsies during the first year of IMI's CANCER-ID

Researchers

Presenter

  • Thomas Schlange

Principal Investigators

  • Nikolas Stoecklein

  • Rui P. Neves

  • Sabrina Pleier

  • Sebastian Bender

  • Nora Brychta

  • Merlin V. Luetke-Eversloh

  • Kiki Andree

  • Leon Terstappen

  • Thomas Krahn

Medical Centers

  • Bayer Pharma AG, Berlin, Germany

  • University Hospital and Medical Faculty of the Heinrich-Heine University, Dusseldorf, Germany

  • Bayer Pharma AG, Berlin, Germany

  • Faculty of Science and Technology, Medical Cell BioPhysics, Enschede, Netherlands.

Locations

  • Germany

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Breast cancer

  • Lung Cancer

Biomarkers

  • Circulating tumor cells

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved